This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Gabapentin: Difference between revisions
>Unity Initiate article major revision. |
>Unity Added warning panel. |
||
| Line 1: | Line 1: | ||
{{headerpanel|{{DepressantOD|gabapentinoids}}}} | |||
{{SummarySheet}} | {{SummarySheet}} | ||
{{SubstanceBox/GABApentin}} | {{SubstanceBox/GABApentin}} | ||
'''Gabapentin''' (also known as '''Neurontin''') is a [[psychoactive class::depressant]] substance of the [[chemical class::gabapentinoid]] class which is used as an [[anticonvulsant]], [[analgesic]] and [[anxiolytic]]. It was originally developed to treat epilepsy and is currently used to relieve neuropathic pain and [[restless leg syndrome]].<ref>Restless legs syndrome: clinical presentation diagnosis and treatment | http://www.sleep-journal.com/article/S1389-9457(15)00647-4/abstract</ref> It is recommended as a first line agent for the treatment of neuropathic pain arising from diabetic neuropathy, post-herpetic neuralgia, and central neuropathic pain.<ref>EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/20402746</ref> | '''Gabapentin''' (also known as '''Neurontin''') is a [[psychoactive class::depressant]] substance of the [[chemical class::gabapentinoid]] class which is used as an [[anticonvulsant]], [[analgesic]] and [[anxiolytic]]. It was originally developed to treat epilepsy and is currently used to relieve neuropathic pain and [[restless leg syndrome]].<ref>Restless legs syndrome: clinical presentation diagnosis and treatment | http://www.sleep-journal.com/article/S1389-9457(15)00647-4/abstract</ref> It is recommended as a first line agent for the treatment of neuropathic pain arising from diabetic neuropathy, post-herpetic neuralgia, and central neuropathic pain.<ref>EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/20402746</ref> | ||